Innovative Breakthrough: Leading Medical’s 38th Invention Patent Granted—Revamping the Testing Landscape with Freeze-Drying Technology!
Major good news is here! Leading Medical A lyophilized assay reagent for glycated hemoglobin HbA1c, and its preparation method and applications. The invention patent has been officially granted, marking another achievement for the company. Invention Patent No. 38 , The IVD upstream core technology landscape expands into a new domain!

Directly addressing industry pain points
Traditional liquid HbA1c assay reagents have long faced challenges. Insufficient stability, cold-chain transportation, stringent storage requirements, and high logistics costs. These issues make it difficult to adapt to diverse settings, such as primary care, mobile screening, and remote diagnosis and treatment.
Breaking the Impasse with Cutting-Edge Technology
Deep integration of Leading Medical Optimization of Lyophilization Formulation and Preparation Process , successfully developed a lyophilized HbA1c assay reagent, achieving a critical transition from liquid to dry powder and significantly enhancing Stability and ease of storage and transportation 。
✅ Three Core Benefits
1. Stability Enhancement: Significantly improves reagent stability and batch-to-batch consistency, ensuring precise and reliable test results.
2. Hassle-free transportation: Break free from cold-chain constraints, support ambient-temperature storage and transport, and significantly reduce logistics and warehousing costs.
3. Multi‑scenario compatibility: No stringent requirements; fully adaptable to grassroots settings and a wide range of testing scenarios.
Innovative strength reaches a new high.
As of now, Leading Medical A total of 87 patents have been filed. , among which 53 invention patents , 38 authorized invention patents have been obtained. Covering the entire value chain—from microsphere formulation and antibody development to lyophilization processes and reagent applications—this approach leverages proprietary patent barriers to reduce reliance on imports and accelerate the domestic substitution of IVD raw materials.
Uphold integrity and strive for excellence, while relentlessly pursuing innovation! Leading Medical will continue to deepen its expertise in cutting-edge core technologies for precision diagnostics, leveraging patented innovations to drive product evolution and deliver more stable, efficient, and reliable reagents and solutions for applications such as biochemical immunoassays, POCT chromatography, and quantitative assays.
2022-07-26
xy13584019024